AAAAAA
Results: 1-25/38
Authors:
CHOU JCY
DOUYON R
CZOBOR P
VOLAVKA J
COOPER TB
Citation: Jcy. Chou et al., CHANGE IN PLASMA PROLACTIN AND CLINICAL-RESPONSE TO HALOPERIDOL IN SCHIZOPHRENIA AND SCHIZOAFFECTIVE DISORDER, Psychiatry research, 81(1), 1998, pp. 51-55
Authors:
TIIHONEN J
HALLIKAINEN T
LACHMAN H
VOLAVKA J
HIETALA J
POHJALAINEN T
RYYNANEN OP
KAUHANEN J
Citation: J. Tiihonen et al., ASSOCIATION BETWEEN THE GENETIC-POLYMORPHISM OF THE OF THE CATECHOL-O-METHYLTRANSFERASE (COMT) AND TYPE-1 ALCOHOLISM, American journal of medical genetics, 81(6), 1998, pp. 516-516
Authors:
VOLAVKA J
COCCARO E
HIGLEY JD
LINNOILA M
Citation: J. Volavka et al., GENE-EXPRESSION, IMPULSE CONTROL, AND AGGRESSION, Biological psychiatry, 43, 1998, pp. 7-7
Authors:
CARPENTER WT
ZITO JM
VITRAI J
VOLAVKA J
Citation: Wt. Carpenter et al., HYPOTHESIS-TESTING - IS CLOZAPINES SUPERIOR EFFICACY DEPENDENT ON MODERATE D-2 RECEPTOR OCCUPANCY, Biological psychiatry, 43(2), 1998, pp. 79-83
Authors:
VOLAVKA J
Citation: J. Volavka, ARE MEDICATION-FREE PERIODS NECESSARY FOR PHASE-3 TRIALS OF NEW ANTIPSYCHOTIC-DRUGS, Archives of general psychiatry, 55(3), 1998, pp. 280-281
Authors:
LACHMAN HM
NOLAN KA
MOHR P
SAITO T
VOLAVKA J
Citation: Hm. Lachman et al., ASSOCIATION BETWEEN CATECHOL O-METHYLTRANSFERASE GENOTYPE AND VIOLENCE IN SCHIZOPHRENIA AND SCHIZOAFFECTIVE DISORDER, The American journal of psychiatry, 155(6), 1998, pp. 835-837
Authors:
KRAKOWSKI M
CZOBOR P
VOLAVKA J
Citation: M. Krakowski et al., EFFECT OF NEUROLEPTIC TREATMENT ON DEPRESSIVE SYMPTOMS IN ACUTE SCHIZOPHRENIC EPISODES, Psychiatry research, 71(1), 1997, pp. 19-26
Authors:
STROUS RD
BARK N
PARSIA SS
VOLAVKA J
LACHMAN HM
Citation: Rd. Strous et al., ANALYSIS OF A FUNCTIONAL CATECHOL-O-METHYLTRANSFERASE GENE POLYMORPHISM IN SCHIZOPHRENIA - EVIDENCE FOR ASSOCIATION WITH AGGRESSIVE AND ANTISOCIAL-BEHAVIOR, Psychiatry research, 69(2-3), 1997, pp. 71-77
Authors:
VOLAVKA J
Citation: J. Volavka, GENETIC AND NEUROCHEMICAL CORRELATES OF VIOLENCE, Psychiatric annals, 27(10), 1997, pp. 679-682
Authors:
CITROME L
VOLAVKA J
Citation: L. Citrome et J. Volavka, PSYCHOPHARMACOLOGY OF VIOLENCE .1. ASSESSMENT AND ACUTE TREATMENT, Psychiatric annals, 27(10), 1997, pp. 691-695
Authors:
CITROME L
VOLAVKA J
Citation: L. Citrome et J. Volavka, PSYCHOPHARMACOLOGY OF VIOLENCE .2. BEYOND THE ACUTE EPISODE, Psychiatric annals, 27(10), 1997, pp. 696-703
Authors:
VOLAVKA J
Citation: J. Volavka, HOMICIDE - A PSYCHIATRIC PERSPECTIVE - MALMQUIST,CP, The Journal of nervous and mental disease, 185(7), 1997, pp. 471-471
Authors:
VOLAVKA J
LASKA E
BAKER S
MEISNER M
CZOBOR P
KRIVELEVICH I
Citation: J. Volavka et al., HISTORY OF VIOLENT BEHAVIOR AND SCHIZOPHRENIA IN DIFFERENT CULTURES -ANALYSES BASED ON THE WHO STUDY ON DETERMINANTS OF OUTCOME OF SEVERE MENTAL-DISORDERS, British Journal of Psychiatry, 171, 1997, pp. 9-14
Authors:
ZIMBROFF DL
KANE JM
TAMMINGA CA
DANIEL DG
MACK RJ
WOZNIAK PJ
SEBREE TB
WALLIN BA
KASHKIN KB
ADAN F
AINSLIE G
ALLAN E
ATRI P
BAKER R
BEITMAN B
BROWN G
CANIVE J
CARMAN J
DOTT S
EDWARDS J
FENTON W
FREIDLI J
FUNDERBURG L
ERESHEFSKY L
GLADSON M
HAMILTON J
HAQUE S
HARTFORD J
HORNE R
HOUCK C
JAMPALA C
LABELLE A
LARSON G
LESEM M
LISKOW B
MAKELA E
MOORE N
MORPHY M
POSEVER T
RISCH S
ROTROSEN J
SHEEHAN D
SILVERSTONE P
SWANN A
TAPP A
THOMAS M
VOLAVKA J
VORA S
Citation: Dl. Zimbroff et al., CONTROLLED, DOSE-RESPONSE STUDY OF SERTINDOLE AND HALOPERIDOL IN THE TREATMENT OF SCHIZOPHRENIA, The American journal of psychiatry, 154(6), 1997, pp. 782-791
Authors:
VANKAMMEN DP
MCEVOY JP
TARGUM SD
KARDATZKE D
SEBREE TB
ANDORN A
BAKER RW
SCHOOLER NR
BORISON RL
CASEY D
ERESHEFSKY L
FUNDERBERG L
HAMNER M
KARSON C
MARDER S
MCKINNEY W
SMALL JG
TAMMINGA C
TUASON V
VOLAVKA J
CHUNG L
Citation: Dp. Vankammen et al., A RANDOMIZED, CONTROLLED, DOSE-RANGING TRIAL OF SERTINDOLE IN PATIENTS WITH SCHIZOPHRENIA, Psychopharmacology, 124(1-2), 1996, pp. 168-175
Authors:
VOLAVKA J
COOPER TB
LASKA EM
MEISNER M
Citation: J. Volavka et al., PLACEBO WASHOUT IN TRIALS OF ANTIPSYCHOTIC-DRUGS, Schizophrenia bulletin, 22(4), 1996, pp. 567-576
Authors:
CZOBOR P
VOLAVKA J
Citation: P. Czobor et J. Volavka, POSITIVE AND NEGATIVE SYMPTOMS - IS THEIR CHANGE RELATED, Schizophrenia bulletin, 22(4), 1996, pp. 577-590
Authors:
DIAMOND B
BORISON R
POTKIN S
ANAND R
HARTMAN R
HAPPY J
ALPHS L
KARSON C
KENNEDY B
KNESEVICH M
MCEVOY J
VOLAVKA J
Citation: B. Diamond et al., SDZ MAR-327 - ESTABLISHING AN MTD FOR A PUTATIVE NOVEL ANTIPSYCHOTIC AGENT, Psychopharmacology bulletin, 32(3), 1996, pp. 432-432
Authors:
VOLAVKA J
COOPER TB
CZOBOR P
MEISNER M
Citation: J. Volavka et al., EFFECT OF VARYING HALOPERIDOL PLASMA-LEVELS ON NEGATIVE SYMPTOMS IN SCHIZOPHRENIA AND SCHIZOAFFECTIVE DISORDER, Psychopharmacology bulletin, 32(1), 1996, pp. 75-79
Authors:
CZOBOR P
VOLAVKA J
Citation: P. Czobor et J. Volavka, DIMENSIONS OF THE BRIEF PSYCHIATRIC RATING-SCALE - AN EXAMINATION OF STABILITY DURING HALOPERIDOL TREATMENT, Comprehensive psychiatry, 37(3), 1996, pp. 205-215
Authors:
VOLAVKA J
CZOBOR P
Citation: J. Volavka et P. Czobor, INTERICTAL ELECTROENCEPHALOGRAPHIC EFFECTS OF ELECTROCONVULSIVE-THERAPY - CAN THEY ELUCIDATE MECHANISM OF ACTION, Archives of general psychiatry, 53(9), 1996, pp. 826-827
Authors:
VOLAVKA J
CZOBOR P
GOODWIN DW
GABRIELLI WF
PENICK EC
MEDNICK SA
JENSEN P
KNOP J
SCHULSINGER F
Citation: J. Volavka et al., THE ELECTROENCEPHALOGRAM AFTER ALCOHOL ADMINISTRATION IN HIGH-RISK MEN AND THE DEVELOPMENT OF ALCOHOL-USE DISORDERS 10 YEARS LATER - PRELIMINARY FINDINGS, Archives of general psychiatry, 53(3), 1996, pp. 258-263
Authors:
VOLAVKA J
COOPER TB
CZOBOR P
MEISNER M
Citation: J. Volavka et al., THE RELATIONSHIP BETWEEN PLASMA HALOPERIDOL CONCENTRATIONS AND CLINICAL-RESULTS - IN REPLY, Archives of general psychiatry, 53(12), 1996, pp. 1168-1169
Authors:
VOLAVKA J
Citation: J. Volavka, HALOPERIDOL DOSING STRATEGIES, The American journal of psychiatry, 153(8), 1996, pp. 1108-1108
Authors:
VOLAVKA J
MOHAMMAD Y
VITRAI J
CONNOLLY M
STEFANOVIC M
FORD M
Citation: J. Volavka et al., CHARACTERISTICS OF STATE-HOSPITAL PATIENTS ARRESTED FOR OFFENSES COMMITTED DURING HOSPITALIZATION, Psychiatric services, 46(8), 1995, pp. 796-800